Relationship between structure and drug-induced parkinsonism.
Sawada
Y
Y
Nasu
R
R
Matsuo
H
H
Ohtani
H
H
D014150:Antipsychotic Agents / Q000009:adverse effects*; D002375:Catalepsy / Q000139:chemically induced; D002936:Cinnarizine / Q000009:adverse effects; D015195:Drug Design; D005444:Flunarizine / Q000009:adverse effects; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D013329:Structure-Activity Relationship; D014665:Vasodilator Agents / Q000009:adverse effects*
D014150:Antipsychotic Agents; D014665:Vasodilator Agents; D002936:Cinnarizine; D006220:Haloperidol; D005444:Flunarizine